Showing results (571-580 of 883) with videos related to

Sort By:
Pageof 89
Arteriosclerosis (Dallas, Tex.)|May 1, 1989
Apolipoprotein, low density lipoprotein subfraction, and insulin associations with familial combined hyperlipidemia. Study of Utah patients with familial dyslipidemic hypertensionS C Hunt, L L Wu, P N Hopkins, et al.
Transfusion|November 17, 2010
Hospital blood bank information systems accurately reflect patient transfusion: results of a validation studyZoe K McQuilten, Nikita Schembri, Mark N Polizzotto, et al.
International Journal of Radiation Oncology, Biology, Physics|August 24, 2010
Timing of radiotherapy and outcome in patients receiving adjuvant endocrine therapyPer Karlsson, Bernard F Cole, Marco Colleoni, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 2018
MOTHER-OF-FT-AND-TFL1 represses seed germination under far-red light by modulating phytohormone responses in Arabidopsis thalianaFabián E Vaistij, Thiago Barros-Galvão, Adama F Cole, et al.
Experimental Eye Research|October 1, 1984
Effects of VIIth (facial) nerve degeneration on vasoactive intestinal polypeptide and substance P levels in ocular and orbital tissues of the rabbitJ M Butler, G L Ruskell, D F Cole, et al.
Clinical Colorectal Cancer|September 10, 2009
Brain metastases from colorectal cancer: risk factors, incidence, and the possible role of chemokinesJohn P Mongan, Camilo E Fadul, Bernard F Cole, et al.
Clinical Immunology (Orlando, Fla.)|July 20, 2005
Impaired cytolytic activity in peripheral blood T cells from renal cell carcinoma patientsTodd S Crocenzi, Christopher P G Tretter, Thomas Schwaab, et al.
Public Health Action|January 27, 2017
Isoniazid preventive treatment among child contacts of adults with smear-positive tuberculosis in The GambiaU Egere, A Sillah, T Togun, et al.
Clinical Colorectal Cancer|May 9, 2009
Brain metastases from colorectal cancer: risk factors, incidence, and the possible role of chemokinesJohn P Mongan, Camilo E Fadul, Bernard F Cole, et al.
Cancer Chemotherapy and Pharmacology|April 27, 2002
The pharmacokinetics of the bispecific antibody MDX-H210 when combined with interferon gamma-1b in a multiple-dose phase I study in patients with advanced cancerLionel D Lewis, Andrew P Beelen, Bernard F Cole, et al.
Pageof 89